德明利(001309.SZ):暫無無人駕駛領域相關技術儲備
格隆匯7月18日丨有投資者通過互動平台向德明利(001309.SZ)提問:您好董祕,近期蘿蔔無人駕駛汽車迅速落地,幾大一線城市也在如火如荼的開啟無人駕駛服務,智能芯片發揮了重大作用,請問貴司在無人駕駛領域有哪些方向技術儲備?未來是否有大力發展該方向計劃?謝謝!
德明利(001309.SZ)回覆:公司主要產品為各類存儲模組,暫無無人駕駛領域相關技術儲備。整車電動化、網聯化、智能化趨勢下車規級存儲需求上升,公司已有部分車規級存儲產品可應用於車載設備,未來公司將加快車規級存儲產品的研發創新,進一步增強市場綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.